首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism
【24h】

A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism

机译:一种基于维生素D的新型多维列线图,用于诊断原发性甲状旁腺功能亢进

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To refine the diagnostic criteria for primary hyperparathyroidism (1°HPT) to identify atypical patients, in whom serum calcium, parathyroid hormone (PTH), or both are within the "normal" range.Methods: Total serum calcium, intact PTH, and 25-hydroxyvitamin D [25(OH)D] levels were measured in patients with 1°HPT and healthy patient groups. Multivariate analysis of healthy patient data first identified factors that significantly affected PTH levels and defined a new PTH reference range with a mathematical model. That nomogram was then validated for prediction of atypical 1°HPT in patients with surgically confirmed disease.Results: On multivariate analysis, calcium (P = .0002), 25(OH)D (P<.0001), and age (P = .015) independently affected PTH. With these variables, we created a 4-dimensional nomogram that distinguished normal patients from those with hyperparathyroid states. Mathematically, this nomogram predicts 1°HPT when the measured serum PTH value is higher than PTH calculated by the following formula: PTH (pg/mL) = 120 - [6 × calcium (mg/dL)] - [0.52 × 25(OH)D (ng/mL)] + [0.26 × patient age (years)]. When applied to our surgical group of patients, this nomogram successfully identified 100% of patients (238 of 238) with classic 1°HPT, 84% (64 of 76) with normocalcemic 1°HPT, and 54% (20 of 37) with 1°HPT and normal PTH.Conclusion: This study uniquely defines a patient-specific upper limit of normal for PTH based on the readily available variables of serum calcium, 25(OH)D, and patient age. Our nomogram may allow for more rapid definitive diagnosis and treatment of 1°HPT in patients with atypical presentations.
机译:目的:完善原发性甲状旁腺功能亢进症(1°HPT)的诊断标准,以识别血清钙,甲状旁腺激素(PTH)或两者均在“正常”范围内的非典型患者。方法:血清总钙,完整PTH,在1°HPT的患者和健康患者组中测量了25-羟基维生素D [25(OH)D]水平。健康患者数据的多变量分析首先确定了显着影响PTH水平的因素,并通过数学模型定义了新的PTH参考范围。然后验证该诺模图是否可用于预测手术确认的疾病患者的非典型1°HPT结果。通过多变量分析,钙(P = .0002),25(OH)D(P <.0001)和年龄(P = .015)独立影响PTH。利用这些变量,我们创建了4维列线图,以区分正常患者和甲状旁腺功能亢进患者。从数学上讲,当测得的血清PTH值高于通过以下公式计算的PTH时,该诺模图预测为1°HPT:PTH(pg / mL)= 120-[6×钙(mg / dL)]-[0.52×25(OH) )D(ng / mL)] + [0.26×患者年龄(年)]。当应用于我们的外科手术患者组时,该列线图成功地识别出100%的经典1°HPT患者(238个中的238个),84%(76个中的64个)正常血钙1°HPT的患者和54%(37个的20个) 1°HPT和正常PTH。结论:本研究基于血清钙,25(OH)D和患者年龄的现成变量,唯一定义了患者特定的PTH正常上限。我们的诺模图可以对非典型表现的患者进行更快的1°HPT的明确诊断和治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号